Minocycline modulates chemokine receptors but not interleukin-10 mRNA expression in hypoxic-ischemic neonatal rat brain

Journal of Neuroscience Research

Volumn 85, Issue 11, 2007, Pages 2450-2459

  Kremlev, Sergey G ^a,b   Roberts, Rebecca L ^a   Palmer, Charles ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokine; Hypoxia ischemia; Inflammation; Minocycline

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MINOCYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; FUNCTIONAL LATERALITY; HYPOXIA-ISCHEMIA, BRAIN; INTERLEUKIN-10; MINOCYCLINE; NEUROPROTECTIVE AGENTS; RATS; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34547640300     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21380     Document Type: Article

References (70)

1. Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, Patel IR, Abramson SB. 1996. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci U S A 93:14014-14019.
2. Arvin KL, Han BH, Du Y, Lin SZ, Paul SM, Holtzman DM. 2002. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 52:54-61.
3. Bachis A, Colangelo AM, Vicini S, Doe PP, De Bernardi MA, Brooker G, Mocchetti I. 2001. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J Neurosci 21:3104-3112.
4. Banati KB, Gehrmann J. 1993. Cytotoxicity of microglia. Glia 7:111-118.
5. Cai Z, Lin S, Fan L-W, Pang Y, Rhodes PG. 2006. Minocycline alleviates hypoxic-ischemic injury to developing olygodendrocytes in the neonatal rat brain. J Neurosci 137:425-435.
6. Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM, Hobbs W, Vonsattel JP, Cha JH, Friedlander RM. 2000. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6:797-801.
7. Cowell RM, Haiyan Xu, Parent JM, Silverstein FS. 2006. Microglial expression of chemokine receptor CCR5 during rat forebrain development and after perinatal hypoxia-ischemia. J Neuroimmunol 173:155-165.
8. De Keyser J, Suiter G, Luiten PG. 1999. Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? Trends Neurosci 22:535-540.
9. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220.
10. Diab A, Abdalla H, Li HL, Shi FD, Zhu J, Hojberg B, Lindquist L, Wretlind B, Bakhiet M, Link H. 1999. Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1alpha attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis. Infect Immun 67:2590-2601.
11. Dietrich WD, Busto R, Bethea JR. 1999. Postischemic hypothermia and IL-10 treatment provide long-lasting neuroprotection of CA1 hippocampus following transient global ischemia in rats. Exp Neurol 158:444-450.
12. Dommergues M-A, Plaisant F, Verney C, Gressens P. 2003. Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection. J Neurosci 121:619-628.
13. Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, Triarhou LC, Chernet E, Perry KW, Nelson DLG, Luecke S, Phebus LA, Bymaster FP, Paul SM. 2001. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci U S A 98:14669-14674.
14. Fan L-W, Pang Y, Lin S, Rhodes PG, Cai Z. 2005a. Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. J Neurosci 133:159-168.
15. Fan L-W, Pang Y, Lin S, Tien L-T, Ma T, Rhodes PG, Cai Z. 2005b. Minocycline reduces lipopolysaccharide-induced neurological dysfunction and brain injury in the neonatal rat. J Neurosci Res 82:71-82.
16. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444-3451.
17. Fox C, Dingman A, Derugin N, Wendland MF, Manabat C, Ji S, Ferriero DM, Vexler ZS. 2005. Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 25:1138-1149.
18. Froen JF, Munkeby BH, Stray-Pedersen B, Saugstad ,OD. 2002. Interleukin-10 reverses acute detrimental effects of endotoxin-induced inflammation on perinatal cerebral hypoxia-ischemia. Brain Res 942:87-94.
19. Ghirnikar RS, Lee YL, Eng LF. 2000. Chemokine antagonist infusion attenuates cellular infiltration following spinal cord contusion injury in rat. J Neurosci Res 59:63-73.
20. Ghirnikar RS, Lee YL, Eng LF. 2001. Chemokine antagonist infusion promotes axonal sparing after spinal cord contusion injury in rat. J Neurosci Res 64:582-589.
21. Gidday JM, Fitzgibbons JC, Shah AR, Park TS. 1994. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett 168:221-224.
22. Giulian D, Vaca K. 1993. Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system. Stroke 24:1-84-1-90.
23. Glass WG, Liu MT, Kuziel WA, Lane TE. 2001. Reduced macrophage infiltration and demyelination in mice lacking the chemokine receptor CCR5 following infection with a neurotropic coronavirus. Virology 288:8-17.
24. Golub LM, McNamara TF, D'Angelo G, Greenwald RA, Ramamurthy NS. 1987. A non-antibacterial chemically modified tetracycline inhibits mammalian collagenase activity. J Dent Res 66:1310-1314.
25. Grilli M, Barbieri I, Basudev H, Brusa R, Casati C, Lozza G. Ongini E. 2000. Interleukin-10 modulates neuronal threshold of vulnerability to ischemic damage. Eur J Neurosci 12:2265-2272.
26. Hattori H, Morin AM, Schwartz PH, Fujikawa DG, Wasterlain CG. 1989. Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat. Neurology 39:713-718.
27. Hayakawa T, Higuchi Y, Nigami H, Hattori H. 1994. Zonisamide reduces hypoxic-ischemic brain damage in neonatal rats irrespective of its anticonvulsive effect. Eur J Pharmacol 257:131-136.
28. Hayzer DJ, Brinson E, Runge MS. 1992. A rat beta-interferon-induced mRNA: sequence characterization. Gene 117:277-278.
29. Hedtjarn M, Mallard C, Eklind S, Gustafson-Brywe K, Hadberg H. 2004a. Global gene expression in the immature brain after hypoxia-ischemia. J Cereb Blood Metab 24:1317-1332.
30. Hedtjarn M, Mallard C, Hadberg H. 2004b. Inflammatory gene profiling in the developing mouse brain after hypoxia-ischemia. J Cereb Blood Metab 24:1333-1351.
31. Holtzman DM, Sheldon RA, Jaffe W, Cheng Y, Ferriero DM. 1996. NGF protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 39:114-122.
32. Ishida A, Trescher WH, Lange MS, Johnston MV. 2001. Prolonged suppression of brain nitric oxide synthase activity by 7-nitroindazole protects against cerebral hypoxic-ischemic injury in neonatal rat. Brain Dev 23:349-354.
33. Ivacko JA, Sun R, Silverstein FS. 1996. Hypoxic-ischemic brain injury induces an acute microglial reaction in perinatal rats. Pediatr Res 39:39-47.
34. Johnston MV, Trescher WH, Ishida A, Nakajima W. 2000. Novel treatments after experimental brain injury. Semin Neonatol 5:75-86.
35. Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD. 1995. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 155:5003-5010.
36. Kaufmann A, Salentin R, Gemsa D, Sprenger H. 2001. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages. J Leukocyte Biol 69:248-252.
37. Kennedy KJ, Strieter RM, Kunkel SL, Lukacs NW, Karpus WJ. 1998. Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1 alpha and monocyte chemotactic protein-1. J Neuroimmunol 92:98-108.
38. Kremlev SG, Palmer C. 2005. Interleukin-10 inhibits endotoxin-induced proinflammatory cytokines in microglial cell cultures. J Neuroimmunol 162:71-80.
39. Kremlev SG, Roberts RL, Palmer C. 2004. Differential expression of chemokines and chemokine receptors during microglial activation and inhibition. J Neuroimmunol 149:1-9.
40. Kreutzberg GW. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
41. Kriz J, Nguyen MD, Juien P. 2002. Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 10:268-278.
42. Kyoungho S. 2004. Minocycline suppresses hypoxic activation of rodent microglia in culture. Neuroscience Letters. 366:167-171.
43. Lai AY, Todd KG. 2006. Hypoxia-activated microglial mediators of neuronal survival are differentially regulated by tetracyclines. Glia 53:809-816.
44. Ledeboer A, Sloane EM, Milligan ED, Frank MG, Mahony JH, Maier SF, Watkins LR. 2005. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115:71-83.
45. Leviton A, Gilles FH. 1984. Acquired perinatal leukoencephalopathy. Ann Neurol 16:1-8.
46. Lu D-Y, Liou H-C, Tang C-H, Fu W-M. 2006. Hypoxia-induced iNOS expression in microglia is regulated by the PI3-kinase/Akt/mTOR signaling pathway and activation of hypoxia inducible factor-1a. Biochem Pharmacol 72:992-1000.
47. Mesples B, Plaisant F, Gressens P. 2003. Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice. Brain Res Dev Brain Res 141:25-32.
48. Molina-Holgado E, Vela JM, Arevalo-Martin A, Guaza C. 2001. LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur J Neurosci 13:493-502.
49. Perrin FE, Lacroix S, Aviles-Trigueros M, David S. 2005. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1 beta in Wallerian degeneration. Brain 128:854-866.
50. Popovic N, Schubart A, Goetz BD. 2002. Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann Neurol 51:215-223.
51. Pousset F, Cremona S, Dantzer R, Kelley KW, Parnet P. 2001. IL-10 and IL-4 regulate type-I and type-II IL-1 receptors expression on IL-1 beta-activated mouse primary astrocytes. J Neurochem 79:726-736.
52. Ransohoff RM, Kivisakk P, Kidd G. 2003. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 3:569-581.
53. Rice J, Vanucci R, Brierley J. 1981. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 9:131-141.
54. Sirimanne ES, Guan J, Williams CE, Gluckman PD. 1994. Two models for determining the mechanisms of damage and repair after hypoxic-ischemic injury in the developing rat brain. J Neurosci Methods 55:7-14.
55. Takami S, Minami M, Nagata I, Namura S, Satoh M. 2001. Chemokine receptor antagonist peptide, viral MIP-II, protects the brain against focal cerebral ischemia in mice. J Cereb Blood Flow Metab 21:1430-1435.
56. Thomas M, Le WD. 2004. Minocycline: neuroprotective mechanisms in Parkinson's disease. Curr Pharm Des 10:679-686.
57. Towfighi J, Zee N, Housman C, Vannucci RC. 1995. Temporal evolution of neuropathologic changes in an immature rat model of cerebral hypoxia: a light microscopic study. Acta Neuropathologica 90:375-386.
58. Tsuji M, Higuchi Y, Shiraishi K, Kume T, Akaike A, Hattori H. 2000. Protective effect of aminoguanidine on hypoxic-ischemic brain damage and temporal profile of brain nitric oxide in neonatal rat. Pediatr Res 47:79-83.
59. Tsuji M, Wilson MA, Lange MS, Johnston MV. 2004. Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. J Exp Neurol 189:58-65.
60. Vanucci R. 1990. Experimental biology of cerebral hypoxia-ischemia: relation to perinatal brain damage. Pediatr Res 27:317-326.
61. Volpe JJ. 1997. Brain injury in the premature infant - from pathogenesis to prevention. Brain Dev 19:519-34.
62. Volpe JJ. 2001. Neurology of the newborn, 4th ed. Philadelphia: Saunders.
63. Wang J, Crawford K, Yuan M, Wang H, Gorry PR, Gabuzda D. 2002. Regulation of CC chemokine receptor 5 and CD4 expression and human immunodeficiency virus type 1 replication in human macrophages and microglia by T helper type 2 cytokines. J Infect Dis 185:885-897.
64. Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Cattaneo E, Ferrante RJ, Kristal BS, Friedlander RM. 2003. Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease. Proc Natl Acad Sci U S A 100:10483-10487.
65. Whitelaw A. 2000. Systematic review of therapy after hypoxic-ischaemic brain injury in the perinatal period. Semin Neonatol 5:33-40.
66. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S. 2002. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22:1763-1771.
67. Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J. 1998. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A 95:15769-15774.
68. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J. 1999. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Nad Acad Sci U S A 96:13496-13500.
69. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, Sarang S, Liu AS, Hartley DM, Wu du C, Gullans S, Ferrante RJ, Przedborski S, Kristal BS, Friedlander RM. 2002. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417:74-78.
70. Zou LP, Pelidou SH, Abbas N, Deretzi G, Mix E, Schaltzbeerg M, Winblad B, Zhu J. 1999. Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats. J Neuroimmunol 98:168-175.